Chemrj 2017 02 01 42 45
Chemrj 2017 02 01 42 45
Chemrj 2017 02 01 42 45
ISSN: 2455-8990
Research Article CODEN(USA): CRJHA5
Shashank Shekhar Mishra*1, Chandra Shekhar Sharma1, Hamendra Pratap Singh1, Neeraj
Kumar2, Harshda Pandiya3
1
Department of Pharmaceutical Chemistry, Bhupal Nobles’ College of Pharmacy, Udaipur 313001, India
2
Department of Pharmaceutical Chemistry, Geetanjali Institute of Pharmacy, Udaipur 313001, India
3
Bhupal Nobles’ College of Pharmacy, Udaipur 313001, India
Abstract Major depressive disorders affect the general health and reduce the life quality. The treatments approaches
are used to treat major depressive disorders are counselling and antidepressant medication. Due to occurrence of
serious but low adverse events, there is essential need to design and develop new drug with lesser toxic and higher
potency. In this work, we performed the evaluation of pharmacokinetic descriptors, bioactivity score and various
types of toxicities through computational methods.
42
Mishra SS et al Chemistry Research Journal, 2017, 2(1):42-45
based virtual screening, bioactivity prediction and data visualization. Molinspiration tools are written in Java,
therefore can be used practically on any computer platform [4]. Drug-likeness is qualitative concept used for drug
like property that described as a complex balance of various molecular properties and structural features which
determine whether particular molecule is similar to the known drugs. These molecular properties are mainly
hydrophobicity, electronic distribution, hydrogen bonding characteristics, molecule size and flexibility and of course
presence of various pharmacophoric features that influence the behaviour of molecule in a living organism,
including bioavailability, transport properties, affinity to proteins, reactivity, toxicity, metabolic stability and many
others. Drug-likeness evaluated by the Lipinski rule of five that deals four simple physicochemical parameter ranges
(MWT ≤ 500, log P ≤ 5, Hbond donors ≤ 5, H-bond acceptors ≤ 10) associated with 90% of orally active drugs that
have passed phase II clinical status [5]. Other calculation methods such as ligand efficiency and lipophilic efficiency
can also be used to express drug-likeness as parameters of potency.
43
Mishra SS et al Chemistry Research Journal, 2017, 2(1):42-45
Among selected antidepressant agents, all are found to be within acceptable range. The MLogP (octanol / water
partition co efficient) of all agents were calculated and found to be within acceptable range according to Lipinski’s
rule. The MLogP value is used to calculate the lipophilic efficiency that measures the potency of drug. Therefore
Octanol-water partition coefficient logP value is essential in rational drug design and QSAR studies. In the
pharmacokinetic study, hydrophobicity of the molecule is assessed by evaluating logP value because hydrophobicity
plays a vital role in the distribution of the drug in the body after absorption [7]. TPSA (Topological Polar Surface
Area) is a very useful physiochemical parameter of molecule that gives the information about polarity of
compounds. This parameter was evaluated for analyzing drug transport properties. Polar surface area is the sum of
all polar atoms mainly oxygen and nitrogen including attached hydrogen [8]. Percent absorption were also evaluated
for all selected antiepileptic agents by %ABS = 109- (0.345 * TPSA) [9]. Molecular volume assesses the transport
properties of the molecule such as blood-brain barrier penetration. The number of rotatable bond was calculated and
have found relevant. A molecule which have more number of rotatable bond become more flexible and have good
binding affinity with binding pocket.
Bioactivity of all selected antimalarial agents was evaluated against six different protein structures. Biological
activity is measured by bioactivity score that are categorized under three different ranges-
1. If bioactivity score is more than 0.00, having considerable biological activity.
2. If bioactivity score is 0.5 to 0.00, having moderately activity.
3. If bioactivity score is less than -0.50, having inactivity [10].
The result of this study was found that the selected agents are biologically active and have physiological effect. The
bioactivity score profile of the all selected agents is given in Table 2.
Imipramine, Doxepine, Fluoxetine and Sertraline having good bioactivity score against GPCR ligand which could
indicates they could bind more effectively with GPCR.
The bioactivity score provide the information about the binding cascade of the drugs that is used for the
development of a new functional drug with increased binding selectivity profile and less undesirable effects.
Table 2: Bioactivity of Antidepressant agents
Name GPCR Ion channel Kinase Nuclear receptor Protease Enzyme
Ligand modulator inhibitor ligand inhibitor inhibitor
Isocarboxazide -0.46 -0.63 -0.74 -1.10 -0.60 -0.41
Phenelzine -1.14 -1.07 -1.32 -1.81 -0.94 -0.40
Pargyline -0.44 -0.21 -0.78 -0.98 -0.63 -0.09
Imipramine 0.25 0.16 0.10 0.00 -0.08 0.13
Doxepine 0.70 0.34 0.08 0.58 0.11 0.65
Bupropion -0.29 0.04 -0.86 -0.61 -0.19 -0.28
Fluoxetine 0.38 0.04 0.13 0.37 0.18 0.19
Sertraline 0.23 0.27 -0.37 -0.16 -0.12 0.02
44
Mishra SS et al Chemistry Research Journal, 2017, 2(1):42-45
All selected antidepressant agents were evaluated to toxicity profile and given in Table 3. All of the drugs were
found to be highly probable to toxicity except sertraline, doxepine and pargyline.
These research findings provide the lead for the design and development of new potent antimalarial drugs.
Computational study of all selected antimalarial drugs gives the information about the pharmacokinetics of the
existing drugs that provide the lead for development of functional drug with more effectiveness and lesser toxicity.
Table 3: Toxicity Profile of Antidepressant agents
Immunotoxicity
Overall toxicity
Teratogenicity
Neurotoxicity
Mutagenicity
Oncogenicity
Sensitivity
Irritation
Name Toxicity
References
1. Becker, S. J., Sanchez, C. C., Curry, J. F., & Tonev, S. S. S. (2008). Cognitive-behavioral therapy for
adolescent depression: processes of cognitive change. Psychiatric Times, 25(14), 46-46.
2. Lynch, V. A., & Duval, J. B. (2010). Forensic nursing science. Elsevier Health Sciences.
3. Flannelly, K. J., Galek, K., Ellison, C. G., & Koenig, H. G. (2010). Beliefs about god, psychiatric
symptoms, and evolutionary psychiatry. Journal of Religion and Health, 49(2), 246-261.
4. Sharma, C. S., Mishra, S. S., Singh, H. P., Kumar, N. (2016). In silico ADME and Toxicity Study of Some
Selected Antineoplastic Drugs. International Journal of Pharmaceutical Sciences and Drug Research, 8(1),
65-67.
5. Lipinski CA. Lead-and drug-like compounds: the rule-of-five revolution. Drug Discovery Today:
Technologies. 2004; 1(4):337-341.
6. Srimai V, Ramesh M, Parameshwar KS, Parthasarathy T. Computer-aided design of selective Cytochrome
P450 inhibitors and docking studies of alkyl resorcinol derivatives. Medicinal Chemistry Research. 2013;
22(11):5314-5323.
7. Abraham DJ. Burger's medicinal chemistry and drug discovery. Wiley Interscience, 2003.
8. Palm K, Stenberg P, Luthman, K, Artursson P. Polar molecular surface properties predict the intestinal
absorption of drugs in humans. Pharmaceutical research. 1997; 14(5):568-571.
9. Sharma CS, Verma T, Singh HP, Kumar N. Synthesis, characterization and preliminary anticonvulsant
evaluation of some flavanone incorporated semicarbazides. Medicinal Chemistry Research 2014;
23(11):4814-4824.
10. Verma A. Lead finding from Phyllanthus debelis with hepatoprotective potentials. Asian Pacific Journal of
Tropical Biomedicine. 2012; 2(3): S1735-S1737.
45